In 2023, Innovent Biologics completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Innovent Biologics has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Innovent Biologics’s data sources below and access millions more through our Disclosure Search.
In 2023, the total operational greenhouse gas (GHG) emissions of Innovent Biologics amounted to 15,894.42 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Innovent Biologics decreased by 28.73%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a b
In 2023, the total Scope 1 emissions of Innovent Biologics were 65.17 metric tons of CO₂ equivalent (tCO₂e). a
Compared to the previous year (2022), Innovent Biologics's Scope 1 emissions decreased by 2.35%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a b
In 2023, Innovent Biologics reported Scope 2 greenhouse gas (GHG) emissions of 15,829.25 tCO₂e without specifying the calculation method. a
Compared to the previous year (2022), Innovent Biologics's Scope 2 emissions (Unspecified Calculation Method) fell by 28.81% in 2023, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption. a b
In 2023, Innovent Biologics reported its Scope 2 emissions using an unspecified methodology. a
In 2023, Innovent Biologics reported Scope 1 greenhouse gas (GHG) emissions of 65.17 tCO₂e and total revenues of USD 953 millions. This translates into an emissions intensity of 0.07 tCO₂e per millions USD. a
In 2023, Innovent Biologics reported a Scope 1 emissions intensity of 0.07 tCO₂e per millions USD. Compared to the peer group median of 9.75 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
In 2023, Innovent Biologics ranked 3 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
This places Innovent Biologics among the top performers, with one of the lowest emissions intensities relative to peers. a